ID: ALA4526165

Max Phase: Preclinical

Molecular Formula: C42H64N6O11

Molecular Weight: 829.00

Molecule Type: Unknown

Representations

Canonical SMILES:  CCCCCCCCCCCCCCc1ccc(NC(=O)C2=CCN(C)[C@@H]([C@H](O[C@@H]3O[C@H](CN)[C@@H](O)[C@H]3O)[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)C(=O)N2C)cc1

Standard InChI:  InChI=1S/C42H64N6O11/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-26-17-19-27(20-18-26)44-38(54)28-21-23-46(2)31(39(55)47(28)3)36(59-41-35(53)32(50)29(25-43)57-41)37-33(51)34(52)40(58-37)48-24-22-30(49)45-42(48)56/h17-22,24,29,31-37,40-41,50-53H,4-16,23,25,43H2,1-3H3,(H,44,54)(H,45,49,56)/t29-,31+,32-,33+,34-,35-,36+,37+,40-,41+/m1/s1

Standard InChI Key:  VFBIGODURJJDFK-SROWIPSXSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 829.00

Molecular Weight (Monoisotopic): 828.4633

AlogP: 1.49

#Rotatable Bonds: 21

Polar Surface Area: 242.14

Molecular Species: BASE

HBA: 14

HBD: 7

#RO5 Violations: 3

HBA (Lipinski): 17

HBD (Lipinski): 8

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 9.70

CX Basic pKa: 8.75

CX LogP: 2.81

CX LogD: 1.64

Aromatic Rings: 2

Heavy Atoms: 59

QED Weighted: 0.09

Np Likeness Score: 0.56

References

1. Patel B, Ryan P, Makwana V, Zunk M, Rudrawar S, Grant G..  (2019)  Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.,  171  [PMID:30933853] [10.1016/j.ejmech.2019.01.071]

Source

Source(1):

• Scientific Literature